iv glutathione review philippines FDA Advisory No. 2019-182 || UNSAFE USE OF AS SKIN LIGHTENING AGENT Format_Liquid Variant:50µg Stabilizing the integrity of

iv glutathione review philippines FDA Advisory No. 2019-182 || UNSAFE USE OF AS SKIN LIGHTENING AGENT Format_Liquid Variant:50µg Stabilizing the integrity of

Stabilizing the integrity of intestinal barrier to control arthritis | Arthritis Research & Therapy | Springer Nature Link

doi: 10.1038/s12276-023-01111-z 24 Rendon-MitchellBOchaniMLiJHanJWangHYangHet al

Format_Liquid

Variant:50µg

Side Effects: Sedation Parkinsonism symptoms QT prolongation (may be significant if taking with drugs inhibiting CYP3A4/5 or 2D6) Pharmacokinetics: undergoes rapid hepatic metabolism involving carbonyl reductase and CYP2D6 to 2 deuterated active metabolites α-dihydrotetrabenazine (α-HTBZ) and β-dihydrotetrabenazine (β-HTBZ), with eventual renal elimination of metabolites the α-HTBZ and β-HTBZ metabolites are primarily responsible for the pharmacological & therapeutic effects produced by the parent “prodrug” twice a day dosing effect half life 9.4 hours (Schneider et al, 2021) HT: Resistant Hypertension